Detection of local recurrent prostate cancer after radical prostatectomy in terms of salvage radiotherapy using dynamic contrast enhanced-MRI without endorectal coil

被引:43
|
作者
Rischke, Hans Christian [1 ]
Schaefer, Arnd O. [2 ]
Nestle, Ursula [1 ]
Volegova-Neher, Natalja [1 ]
Henne, Karl [1 ]
Benz, Matthias R. [3 ]
Schultze-Seemann, Wolfgang [4 ]
Langer, Mathias [2 ]
Grosu, Anca L. [1 ]
机构
[1] Univ Freiburg, Dept Radiat Oncol, D-79106 Freiburg, Germany
[2] Univ Freiburg, Dept Diagnost Radiol, D-79106 Freiburg, Germany
[3] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA USA
[4] Univ Freiburg, Dept Urol, D-79106 Freiburg, Germany
来源
RADIATION ONCOLOGY | 2012年 / 7卷
关键词
Prostate cancer; PSA recurrence; Salvage radiotherapy; Dynamic contrast enhanced MRI; Gross tumor volume; ANTIGEN; ANATOMY; BIOPSY; FOSSA; MEN; PSA; US;
D O I
10.1186/1748-717X-7-185
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To evaluate the value of dynamic contrast enhanced Magnetic Resonance Imaging (DCE-MRI) without endorectal coil (EC) in the detection of local recurrent prostate cancer (PC) after radical prostatectomy (RP). Material and methods: Thirty-three patients with recurrent PC underwent DCE-MRI without EC before salvage radiotherapy (RT). At median 15 (mean 16 +/- 4.9, range 12-27) months after completion of RT all patients showed complete biochemical response. Additional follow up post RT DCE-MRI scans were available. Prostate specific antigen (PSA) levels at the time of imaging were correlated to the imaging findings. Results: In 22/33 patients (67%) early contrast enhancing nodules were detected in the post-prostatectomy fossa on pre-RT DCE-MRI images. The average pre-RT PSA level of the 22 patients with positive pre-RT DCE-MRI findings was significantly higher (mean, 0.74 +/- 0.64 ng/mL) compared to the pre-RT PSA level of the 11 patients with negative pre-RT DCE-MRI (mean, 0.24 +/- 0.13 ng/mL) (p<0.001). All post-RT DCE-MRI images showed complete resolution of initial suspicious lesions. A pre-RT PSA cut-off value of >= 0.54 ng/ml readily predicted a positive DCE-MRI finding. Conclusions: This is the first study that shows that DCE-MRI without EC can detect local recurrent PC with an estimated accuracy of 83% at low PSA levels. All false negative DCE-MRI scans were detected using a PSA cut-off of >= 0.54 ng/mL.
引用
收藏
页数:8
相关论文
共 47 条
  • [31] Incremental value of diffusion weighted and dynamic contrast enhanced MRI in the detection of locally recurrent prostate cancer after radiation treatment: preliminary results
    Oguz Akin
    David H. Gultekin
    Hebert Alberto Vargas
    Junting Zheng
    Chaya Moskowitz
    Xin Pei
    Dahlia Sperling
    Lawrence H. Schwartz
    Hedvig Hricak
    Michael J. Zelefsky
    European Radiology, 2011, 21 : 1970 - 1978
  • [32] Comparison of salvage high dose-rate brachytherapy and external beam radiotherapy for treatment of prostate cancer local recurrence after radical prostatectomy
    Pavlov, A. Yu.
    Dzidzaria, A. G.
    Tsibulskiy, A. D.
    Mirzakhanov, R. I.
    ONKOUROLOGIYA, 2023, 19 (02): : 66 - 74
  • [33] Prognostic Parameters, Complications, and Oncologic and Functional Outcome of Salvage Radical Prostatectomy for Locally Recurrent Prostate Cancer after 21st-Century Radiotherapy
    Heidenreich, Axel
    Richter, Stephanie
    Thueer, David
    Pfister, David
    EUROPEAN UROLOGY, 2010, 57 (03) : 437 - 443
  • [34] Recurrent Gleason Score 6 Prostate Cancer After Radiotherapy or Ablation: Should We Observe Them All? Results from a Large Multicenter Salvage Radical Prostatectomy Consortium
    Marra, Giancarlo
    Calleris, Giorgio
    Conte, Francesca
    Benfant, Nicole
    Rajwa, Pawel
    Ahmed, Mohamed
    Abreu, Andre
    Cacciamani, Giovanni
    Smith, Joseph A.
    Joniau, Steven
    Rodriguez-Sanchez, Lara
    Sanchez-Salas, Rafael
    Cathcart, Paul
    Gill, Inderbir
    Karnes, Robert Jeffrey
    Tilki, Derya
    Shariat, Shahrokh F.
    Touijer, Karim
    Gontero, Paolo
    EUROPEAN UROLOGY FOCUS, 2024, 10 (03): : 461 - 468
  • [35] Diagnostic Value of Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Detecting Residual or Recurrent Prostate Cancer After Radical Prostatectomy: A Pooled Analysis of 12 Individual Studies
    Tao Yu
    Nan Meng
    Da Chi
    Yingjie Zhao
    Zhekun Wang
    Yahong Luo
    Cell Biochemistry and Biophysics, 2015, 72 : 687 - 694
  • [36] 18F-Fluorocholine PET/CT Complementing the Role of Dynamic Contrast-Enhanced MRI for Providing Comprehensive Diagnostic Workup in Prostate Cancer Patients With Suspected Relapse Following Radical Prostatectomy
    Vadi, Shelvin Kumar
    Singh, Baljinder
    Basher, Rajender K.
    Watts, Ankit
    Sood, Ashwani K.
    Lal, Anupam
    Kakkar, Nandita
    Singh, S. K.
    CLINICAL NUCLEAR MEDICINE, 2017, 42 (08) : E355 - E361
  • [37] 11C-acetate positron-emission tomography/computed tomography imaging for detection of recurrent disease after radical prostatectomy or radiotherapy in patients with prostate cancer
    Esch, Lukas Hendrik
    Fahlbusch, Melanie
    Albers, Peter
    Hautzel, Hubertus
    Mueller-Mattheis, Volker
    BJU INTERNATIONAL, 2017, 120 (03) : 337 - 342
  • [38] The maximum standardized uptake value in patients with recurrent or persistent prostate cancer after radical prostatectomy and PSMA-PET-guided salvage radiotherapy—a multicenter retrospective analysis
    Simon K. B. Spohn
    Andrea Farolfi
    Sarah Schandeler
    Marco M. E. Vogel
    Juri Ruf
    Michael Mix
    Simon Kirste
    Francesco Ceci
    Stefano Fanti
    Helena Lanzafame
    Francesca Serani
    Christian Gratzke
    August Sigle
    Stephanie E. Combs
    Denise Bernhardt
    Juergen E. Gschwend
    Josef A. Buchner
    Christian Trapp
    Claus Belka
    Peter Bartenstein
    Lena Unterrainer
    Marcus Unterrainer
    Matthias Eiber
    Stephan G. Nekolla
    Kilian Schiller
    Anca L. Grosu
    Nina-Sophie Schmidt-Hegemann
    Constantinos Zamboglou
    Jan C. Peeken
    European Journal of Nuclear Medicine and Molecular Imaging, 2022, 50 : 218 - 227
  • [39] Dose-escalated salvage radiotherapy after radical prostatectomy in high risk prostate cancer patients without hormone therapy: outcome, prognostic factors and late toxicity
    Mohamed Shelan
    Yasser Abo-Madyan
    Grit Welzel
    Christian Bolenz
    Julia Kosakowski
    Nadim Behnam
    Frederik Wenz
    Frank Lohr
    Radiation Oncology, 8
  • [40] Dose-escalated salvage radiotherapy after radical prostatectomy in high risk prostate cancer patients without hormone therapy: outcome, prognostic factors and late toxicity
    Shelan, Mohamed
    Abo-Madyan, Yasser
    Welzel, Grit
    Bolenz, Christian
    Kosakowski, Julia
    Behnam, Nadim
    Wenz, Frederik
    Lohr, Frank
    RADIATION ONCOLOGY, 2013, 8